Contracts › 75A50126F61014
75A50126F61014: Manufacture and Stability Studies of Thimerosal-Free Pandemic Influenza Vaccine Multidose Vials (MDVS)
Awarded to Sanofi Vaccines Us Inc. by Office of Assistant Secretary for Preparedness and Response.
$6.0Mobligated
$19.4Mpotential value
29 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50126F61014 |
|---|---|
| Vehicle | 75A50122D00003 |
| Awardee | Sanofi Vaccines Us Inc. |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | PA |
| Period of performance | 30 September 2026 to 29 September 2027 |
| Potential end | 29 September 2028 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record